Who owns SAREPTA THERAPEUTICS INC NOTE 1.250 9/1?
- CUSIP Number: 803607ad2
Tip: Access positions for across all investors
Analyze quarterly positions in Sarepta Therapeutics Inc Note 1.250 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sarepta Therapeutics Inc Note 1.250 9/1 stock
Who bought or sold SAREPTA THERAPEUTICS INC NOTE 1.250 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 115M | $131M | 351% | Sep 2024 |
|
| Highbridge Capital Management | 60M | $68M | 33% | Sep 2024 |
|
| Calamos Advisors | 59M | $68M | 0% | Sep 2024 |
|
| Tenor Capital Management | 55M | $63B | 100% | Sep 2024 |
|
| Davidson Kempner Capital Management | 50M | $64M | 25% | Jun 2024 |
|
| Advent Capital Management | 46M | $53M | 3% | Sep 2024 |
|
| Steelhead Partners | 45M | $51B | -18% | Sep 2024 |
|
| Lazard Asset Management | 41M | $47M | 2% | Sep 2024 |
|
| BlackRock | 37M | $48M | -30% | Jun 2024 |
|
| Magnetar Financial | 36M | $41M | 100% | Sep 2024 |
|
| State Street Corporation | 23M | $30M | -6% | Jun 2024 |
|
| OZ Management | 18M | $20M | -30% | Sep 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 14M | $16M | 2% | Sep 2024 |
|
| Lord, Abbett & Co | 11M | $12M | -2% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 11M | $12M | 18% | Sep 2024 |
|
| BlackRock | 9.4M | $11M | 100% | Sep 2024 |
|
| CNH Partners | 9.2M | $11M | 1% | Sep 2024 |
|
| Gabelli Funds | 8.4M | $9.6M | 14% | Sep 2024 |
|
| Partner Fund Management | 7.8M | $8.8M | 0% | Sep 2024 |
|
| SSI Investment Management | 7.1M | $8.1M | -3% | Sep 2024 |
|
| CSS | 7.0M | $8.0M | -7% | Sep 2024 |
|
| Oaktree Capital Management | 6.5M | $7.4M | 226% | Sep 2024 |
|
| Morgan Stanley | 6.1M | $7.9M | -25% | Jun 2024 |
|
| Jpmorgan Chase & Co | 5.8M | $6.6M | 39% | Sep 2024 |
|
| RWC Asset Management | 5.4M | $6.1M | 23% | Sep 2024 |
|
| Invesco | 4.9M | $5.6M | 0% | Sep 2024 |
|
| New York State Common Retirement Fund | 4.5M | $5.1M | 15% | Sep 2024 |
|
| Bnp Paribas Investment Partners | 4.4M | $5.0M | -9% | Sep 2024 |
|
| Citigroup | 4.2M | $4.7M | -25% | Sep 2024 |
|
| Ofi Invest Asset Management | 4.0M | $4.8M | 0% | Jun 2024 |
|
| Balyasny Asset Management | 4.0M | $5.2M | 100% | Jun 2024 |
|
| Man Group | 3.9M | $4.4M | 0% | Sep 2024 |
|
| Amundi | 3.5M | $3.9M | 0% | Sep 2024 |
|
| Royal Bank of Canada | 3.4M | $3.9M | -16% | Sep 2024 |
|
| Franklin Resources | 3.2M | $3.7M | -19% | Sep 2024 |
|
| Capstone Investment Advisors | 2.5M | $2.8M | -50% | Sep 2024 |
|
| Macquarie Group | 2.3M | $2.9M | 29% | Jun 2024 |
|
| Wellesley Investment Advisors | 2.0M | $2.3B | -22% | Sep 2024 |
|
| Nicholas Investments Partners | 1.9M | $2.1M | 0% | Sep 2024 |
|
| Palisade Capital Management | 1.8M | $2.3M | 0% | Jun 2024 |
|
| Westwood Holdings | 1.5M | $170M | 200% | Sep 2024 |
|
| Wells Fargo & Company | 1.4M | $1.6M | -85% | Sep 2024 |
|
| Bank of America Corporation | 1.3M | $1.5M | -93% | Sep 2024 |
|
| Shenkman Capital Management | 1.1M | $1.3B | -58% | Sep 2024 |
|
| Barclays | 864k | $983k | -82% | Sep 2024 |
|
| Bank of New York Mellon | 800k | $910k | -11% | Sep 2024 |
|
| Zurcher Kantonalbank | 450k | $498k | -40% | Sep 2024 |
|
| Central Pacific Bank - Trust Division | 393k | $446k | 0% | Sep 2024 |
|
| Russell Investments | 382k | $494k | 0% | Jun 2024 |
|
| Dnca Finance | 370k | $421k | 100% | Sep 2024 |
|
| Teton Advisors | 350k | $398k | 40% | Sep 2024 |
|
| SG Americas Securities | 295k | $34M | -2% | Sep 2024 |
|
| KBC Group NV | 200k | $227k | 0% | Sep 2024 |
|
| GAMCO Asset Management | 200k | $259k | 100% | Jun 2024 |
|
| Nomura Holdings | 159k | $20M | 0% | Sep 2024 |
|
| First Hawaiian Bank | 112k | $127k | 0% | Sep 2024 |
|
| Calamos Wealth Management | 81k | $92k | 0% | Sep 2024 |
|
| Leucadia National Corporation | 40k | $52k | 100% | Jun 2024 |
|
| Oaktree Fund Advisors | 26k | $30k | 136% | Sep 2024 |
|
| Raymond James & Associates | 21k | $24k | 62% | Sep 2024 |
|
| Rsm Us Wealth Management | 17k | $19k | 13% | Sep 2024 |
|
| Stonegate Investment Group | 13k | $15k | 0% | Sep 2024 |
|
| Rothschild Investment | 1.0k | $1.1k | 0% | Sep 2024 |
|
| Alken Asset Management | 850.00 | $966k | 100% | Sep 2024 |
|
| Candriam Luxembourg S.C.A. | 450.00 | $583k | -25% | Jun 2024 |
|
Who sold out of Sarepta Therapeutics Inc Note 1.250 9/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Braidwell | Jun 2024 | 43M | $56M |
| Wolverine Asset Management | Jun 2024 | 27M | $34M |
| Readystate Asset Management | Jun 2024 | 23M | $29M |
| Nuveen Asset Management | Mar 2024 | 20M | $23M |
| Mint Tower Capital Management B.V. | Mar 2024 | 6.0M | $7.0M |
| Healthcare Of Ontario Pension Plan Trust Fund | Jun 2024 | 3.0M | $3.9M |
| Toronto-Dominion Bank | Jun 2024 | 2.5M | $3.2M |
| Groupama Asset Managment | Jun 2024 | 1.3M | $1.7M |
| Agf Management | Jun 2024 | 1.2M | $1.5M |